Skip to content

A double-blind randomized controlled trial comparing PArietene self-fixing semi-Resorbable mesh with standard heavy-weight polypropylene mesh on chronic inguinal pAin DEvelopment

A double-blind randomized controlled trial comparing PArietene self-fixing semi-Resorbable mesh with standard heavy-weight polypropylene mesh on chronic inguinal pAin DEvelopment - PARADE trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON31651
Enrollment
350
Registered
2008-03-14
Start date
2008-04-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pain after inguinal hernia repair

Interventions

In the studygroup the Parietene lightweight self-fixing mesh (Tyco-Sofradim) is used. In the controlgroup a standard polypropylene mesh is used. both groups are treated according to the Lichtenstein

Sponsors

Tyco Health Care
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Primary unilateral inguinal hernia 2. Age: * 18 years old

Exclusion criteria

Exclusion criteria: 1. Signs of incarceration 2. Signs of local infection 3. Presence of chronic inguinal pain following a previous vasectomy, Pfannenstiel incision, appendectomy 4. ASA IV 5. Adequate follow up not possible: mental retardation, dementia, foreign language, living in asylum seekers centre

Design outcomes

Primary

MeasureTime frame
Pain assessment (6-point Verbal Rating Scale and Surgical Pain Scales)

Secondary

MeasureTime frame
Recurring inguinal hernia (physical examination/ ultrasonography), peri- and early postoperative complications (questionnaire), return to daily actvities (questionnaire), quality of life (SF-36)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)